Shanghai Pharmaceuticals (02607) Announces Proxy Form for December 2025 EGM

Bulletin Express11-18

Shanghai Pharmaceuticals Holding Co., Ltd. (02607) has issued a proxy form for an Extraordinary General Meeting scheduled on 9 December 2025 at 14:00. The meeting will take place at Meeting Room, 2nd Floor, Shanghai Pharma Building, No. 200 Taicang Road, Huangpu District, Shanghai.

The agenda includes one special resolution involving the abolishment of the supervisory board and corresponding amendments to the Articles of Association and its appendices. There are also three ordinary resolutions, covering proposed amendments to the Implementation Rules of the Cumulative Voting System and to the Administrative Measures for Raised Funds, as well as a 2025 Interim Profit Distribution Plan.

Shareholders must submit the completed proxy form and relevant documents to the designated H Share registrar at least 24 hours prior to the meeting. Attendance and voting can be in person or by proxy. If no voting instructions are specified on the proxy form, the appointed proxy will vote at their discretion. Shareholders who deliver the required documentation on time retain the option to attend the meeting and vote in person.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1105171929?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-18 17:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105171929","market":"us","top_or_hot":-1,"title":"Shanghai Pharmaceuticals (02607) Announces Proxy Form for December 2025 EGM","media":"Bulletin Express","content":"<p>Shanghai Pharmaceuticals Holding Co., Ltd. (02607) has issued a proxy form for an Extraordinary General Meeting scheduled on 9 December 2025 at 14:00. The meeting will take place at Meeting Room, 2nd Floor, Shanghai Pharma Building, No. 200 Taicang Road, Huangpu District, Shanghai.</p>\n<p>The agenda includes one special resolution involving the abolishment of the supervisory board and corresponding amendments to the Articles of Association and its appendices. There are also three ordinary resolutions, covering proposed amendments to the Implementation Rules of the Cumulative Voting System and to the Administrative Measures for Raised Funds, as well as a 2025 Interim Profit Distribution Plan.</p>\n<p>Shareholders must submit the completed proxy form and relevant documents to the designated H Share registrar at least 24 hours prior to the meeting. Attendance and voting can be in person or by proxy. If no voting instructions are specified on the proxy form, the appointed proxy will vote at their discretion. Shareholders who deliver the required documentation on time retain the option to attend the meeting and vote in person.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Pharmaceuticals (02607) Announces Proxy Form for December 2025 EGM</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Pharmaceuticals (02607) Announces Proxy Form for December 2025 EGM\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-18 17:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Pharmaceuticals Holding Co., Ltd. (02607) has issued a proxy form for an Extraordinary General Meeting scheduled on 9 December 2025 at 14:00. The meeting will take place at Meeting Room, 2nd Floor, Shanghai Pharma Building, No. 200 Taicang Road, Huangpu District, Shanghai.</p>\n<p>The agenda includes one special resolution involving the abolishment of the supervisory board and corresponding amendments to the Articles of Association and its appendices. There are also three ordinary resolutions, covering proposed amendments to the Implementation Rules of the Cumulative Voting System and to the Administrative Measures for Raised Funds, as well as a 2025 Interim Profit Distribution Plan.</p>\n<p>Shareholders must submit the completed proxy form and relevant documents to the designated H Share registrar at least 24 hours prior to the meeting. Attendance and voting can be in person or by proxy. If no voting instructions are specified on the proxy form, the appointed proxy will vote at their discretion. Shareholders who deliver the required documentation on time retain the option to attend the meeting and vote in person.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02607","symbol_name":"上海医药","start_time":0,"source_url":"","article_id":"1105171929","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105171929","pubTimestamp":1763457737,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Pharmaceuticals Holding Co., Ltd. (02607) has issued a proxy form for an Extraordinary General Meeting scheduled on 9 December 2025 at 14:00. The meeting will take place at Meeting Room, 2nd...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02607":"上海医药"},"translate_title":"上海医药(02607)公布2025年12月临时股东大会代表委任表格","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02607":1},"content_text":"Shanghai Pharmaceuticals Holding Co., Ltd. (02607) has issued a proxy form for an Extraordinary General Meeting scheduled on 9 December 2025 at 14:00. The meeting will take place at Meeting Room, 2nd Floor, Shanghai Pharma Building, No. 200 Taicang Road, Huangpu District, Shanghai.\nThe agenda includes one special resolution involving the abolishment of the supervisory board and corresponding amendments to the Articles of Association and its appendices. There are also three ordinary resolutions, covering proposed amendments to the Implementation Rules of the Cumulative Voting System and to the Administrative Measures for Raised Funds, as well as a 2025 Interim Profit Distribution Plan.\nShareholders must submit the completed proxy form and relevant documents to the designated H Share registrar at least 24 hours prior to the meeting. Attendance and voting can be in person or by proxy. If no voting instructions are specified on the proxy form, the appointed proxy will vote at their discretion. Shareholders who deliver the required documentation on time retain the option to attend the meeting and vote in person.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1105171929","isCrawlerRequest":true}